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Abstract
Background and Purpose: Posttraumatic stress disorder (PTSD) is common in survivors of acute life-threatening illness, but
little is known about the burden of PTSD in survivors of stroke and transient ischemic attack (TIA). This study estimated the
prevalence of stroke or TIA-induced posttraumatic stress disorder (PTSD) using systematic review and meta-analysis.
Methods: Potentially relevant peer-reviewed journal articles were identified by searching the Ovid MEDLINE, PsycINFO,
PILOTS Database, The Cochrane Library and Scopus from inception to January 2013; all searches were conducted on January
31, 2013. Observational cohort studies that assessed PTSD with specific reference to a stroke or TIA that occurred at least 1
month prior to the PTSD assessment were included. PTSD rates and characteristics of the study and sample were abstracted
from all included studies. The coding of all articles included demographics, sample size, study country, and method and
timing of PTSD assessment.
Results: Nine studies (N= 1,138) met our inclusion criteria. PTSD rates varied significantly across studies by timing of PTSD
assessment (i.e., within 1 year of stroke/TIA versus greater than 1 year post-stroke/TIA; 55% of heterogeneity explained;
Q1 = 10.30; P= .001). Using a random effects model, the estimated rate of PTSD following stroke or TIA was 23% (95% CI,
16%–33%) within 1 year of the stroke or TIA and 11% (95% CI, 8%–14%) after 1 year.
Conclusions: Although PTSD is commonly thought to be triggered by external events such as combat or sexual assault,
these results suggest that 1 in 4 stroke or TIA survivors develop significant PTSD symptoms due to the stroke or TIA.
Screening for PTSD in a large population-based prospective cohort study with cardiovascular outcome assessments is
needed to yield definitive prevalence, and determine whether stroke or TIA-induced PTSD is a risk factor for subsequent
cardiovascular events or mortality.
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Introduction
Posttraumatic stress disorder (PTSD) is an anxiety disorder
initiated by exposure to a traumatic event and is characterized by
symptoms of re-experiencing, avoidance of reminders of the event,
persistent negative mood and cognition, and physiological
hyperarousal that persist for at least 1 month after the event.
Observational evidence suggests that PTSD is related to increased
risk of incident cardiovascular disease [1] [2]. A recent meta-
analysis further suggests that PTSD triggered by cardiovascular
events - specifically, acute coronary syndrome (ACS) - is associated
with a doubling of risk for recurrent cardiac events and mortality
[3] [4].
Until recently, only a few studies assessed PTSD due to stroke,
another potentially traumatic acute cardiovascular event. Preva-
lence estimates in these studies has varied from 3–37% [5] [6] [7]
[8] [9] [10] [11] [12]. A more recent study, the largest on this topic
to date, found that 18% of 535 stroke or TIA survivors reported
clinically significant PTSD symptoms. While the association
between stroke or TIA-induced PTSD and risk for recurrent
stroke or other cardiovascular events was not examined, partic-
ipants in this study were nearly three times more likely than those
without PTSD symptoms to report medication nonadherence
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[13]. These data suggest that, similar to ACS-induced PTSD,
stroke or TIA-induced PTSD may increase risk for recurrent
stroke and other cardiovascular events. This meta-analytic review
of cross-sectional studies was designed to estimate the overall
prevalence of PTSD due to stroke or TIA.
Methods
Search Strategy and Selection Criteria
We sought to identify all studies that reported a valid prevalence
estimate of PTSD due to stroke or TIA. Included studies must
have been observational cohorts and must have assessed PTSD
with specific reference to a stroke or TIA that occurred at least 1
month prior to the PTSD assessment. Further, studies must have
used a self-report PTSD screening instrument or clinical interview
designed or specifically altered to query about only stroke or TIA-
induced PTSD. For the one study that reported multiple PTSD
assessments, we abstracted only the earliest estimate (at 1 month
post-stroke) [10].
Potentially relevant peer-reviewed journal articles published in
English were identified by a search of the biomedical electronic
databases Ovid MEDLINE, PsycINFO, PILOTS Database, The
Cochrane Library and Scopus conducted by an information
specialist (L.F.) with expertise in behavioral medicine. Databases
were searched from inception to January 2013; all searches were
conducted on January 31, 2013. All relevant subject headings and
free-text terms were used to represent PTSD and stroke or TIA
and the sets of terms were combined with AND. Terms for
MEDLINE included: exp Stress Disorders, Traumatic/OR
ptsd.tw. OR (post-traumatic OR (post adj traumatic)).tw or
posttraumatic.tw. AND exp stroke/OR Stroke$.tw OR cerebro-
vascular.tw. OR ((brain or vascular or lacunar or venous or
cerebral or isch?emic) adj2 (accident$ or infarct$ or event$ or
attack$)).tw. Search terms were adapted for the other databases.
Additional records were identified by scanning the reference lists
of relevant studies and reviews and by employing the Related
Articles feature in PubMed/Medline and the Cited Reference
Search in Scopus. To determine the studies to be assessed further,
two authors (S.R., D.E.) independently read the title, or title and
abstract of every record retrieved. Opinion differences were
resolved by consensus. All potentially relevant articles were
investigated as full text.
Database Construction and Coding
We abstracted PTSD rates and characteristics of the study and
sample from all included studies (Table 1). The coding of all
articles included demographic information, sample size, study
country, and method and timing of PTSD assessment. We also
evaluated the quality of each study based on the Methodological
Evaluation of Observational Research (MORE)- Observational
Studies of Incidence or Prevalence of Chronic Diseases developed
by the Agency for Healthcare Research and Quality (AHRQ)
[14]. One study’s prevalence estimate, 7 and another’s demo-
graphic characteristics were uncertain [9], so authors were
contacted to obtain this information. We converted one study’s
prevalence estimate to make it consistent with the method used by
the other studies that estimated prevalence using a screening
questionnaire [13]. All studies that were included used either
diagnostic interviews or well-validated self-report screening
questionnaires that assessed PTSD specifically due to stroke or TIA.
Quantitative Methods
Comprehensive Meta-analysis (version 2, BioStat Software,
Engelwood, NJ) served as the statistical platform for completing all
statistical tests and associated graphic results. To summarize the
prevalence findings, we computed prevalence point estimates using
these formulas:
Logit Event Rate = Log [Event Rate/(1 2 Event Rate)].
Event Rate Standard Error = !(1/(Event Rate ?Sample Size)/
(1/[(12Event Rate) ? Sample Size]),
We computed 95% confidence intervals (CIs) using this formula:
Lower Limit = Logit Event Rate 2 (1.96 ? Logit Event Rate
Standard Error).
Upper Limit = Logit Event Rate+(1.96 ? Logit Event Rate
Standard Error).
Results are presented after back-transformation.
There was statistically significant heterogeneity in prevalence
estimates, so random-effects models were used. In addition, we
used sensitivity analyses to assess evidence of moderator effects for
the prevalence results across two methodological factors: (1)
method and (2) timing of PTSD assessment. Finally, we produced
a forest plot and calculated both the classic and Orwin’s fail-safe N
to address the issue of publication bias.
Results
Study Population
Our search identified 1238 articles, and 2 coders agreed that 10
articles required full reading. Of those, 9 met our criteria for
inclusion yielding a total of 1,138 participants (Figure 1). All
participants were enrolled from either the US or Europe. The
mean age of participants was 64.5 and 47.5% were men.
PTSD Assessment
The timing of PTSD assessments ranged from 1 month to 60
months after the stroke or TIA. PTSD was assessed by clinical
interview in 2 studies and using a screening questionnaire in the
remaining 7 studies. Table 1 shows the screening questionnaires
used in each study. While none of the scales have been validated in
stroke or TIA survivors, similar screening questionnaires to those
used in these studies have performed well against diagnostic
interview in ACS patients [3].
Study Quality
All included studies met our minimum criteria for quality. Study
quality across the included studies was highly similar, with very
good internal validity (based primarily on the use of well-validated
PTSD screening questionnaires or clinical interviews) but only
moderate external validity (based on nongeneral population based
sampling, poor reporting of sampling bias, cross-sectional study
design, poor reporting of response rates, and poor reporting of
subgroup estimates across sex, race, and ethnicity groups).
Prevalence
The prevalence estimate of stroke or TIA-induced PTSD across
all studies included in the review was 13% (95% CI, 11%–16%).
However, there was significant heterogeneity in prevalence rates,
with reported rates ranging from 3% to 37% (Q9 = 85.64; P,.001;
I2 = 89.49).
Assessment method. The PTSD prevalence estimate varied
significantly by type of PTSD assessment (21% of heterogeneity
explained; Q1 = 6.83; P= .01). The aggregate prevalence estimate
in the 7 studies in which PTSD was assessed with diagnostic self-
report questionnaires was 28% (95% CI, 18%–41%), compared
with 6% (95% CI, 2%–18%) in the two studies in which PTSD
was assessed with clinical interviews.
Timing of PTSD assessment. The PTSD prevalence
estimate varied significantly by timing of assessment (64% of
Prevalence of PTSD in Survivors of Stroke and TIA
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heterogeneity explained; Q1 = 10.33; P= .001). Of the 9 included
studies, 7 assessed PTSD within 1 month to 1 year after the index
stroke [6] [7] [8] [10] [11] [12]. The other 2 assessed PTSD up to
18 months [9] and 5 years (mean, 1.8 years) [13] after the index
stroke. The aggregate prevalence estimate in the 6 studies in which
participants were assessed within 1 year of the index stroke was
25% (95% CI, 17%–35%), compared with 12% (95% CI, 9%–
15%) in those assessed in studies that allowed more time between
the index stroke and PTSD assessment.
Final estimates. As substantial heterogeneity explained by
timing of PTSD assessment suggested that two underlying
prevalence estimates existed, we conducted another meta-analysis
with the estimates from Kronish et al [13], the study with the
largest sample size, divided into estimates for participants with
index strokes within 12 months (prevalence = 16%) and those with
index strokes greater than 12 months prior to PTSD assessment
(prevalence = 11%). Figure 2 shows the final overall estimate of
13% (95% CI, 11%–16%) from the random effects model
comprised of an aggregate estimate of 23% (95% CI, 16%–
33%) for PTSD within 1 year of stroke and 11% (95% CI, 8%–
14%) after 1 year. Timing of PTSD assessment continued to
explain a significant proportion of the heterogeneity in prevalence
estimates in the final model (55% of heterogeneity explained;
Q1 = 10.30; P= .001).
Assessment of bias. The forest plot given in Figure 3 does
not suggest substantial publication bias. We calculated the classic
fail-safe N, which suggested that 228 unpublished studies with null
results would have to exist for our estimate to become statistically
non-significant. However, in this study, we were more concerned
with the potential influence of unpublished studies on the precision
of our estimate. Orwin’s fail-safe N suggested that only 3
unpublished studies with no PTSD cases would have to exist to
yield an aggregate estimate of 10% (versus the 23% we report) for
the prevalence of PTSD in the first year post-stroke.
Discussion
To our knowledge, this is the first meta-analytic review of stroke
or TIA-induced PTSD. We found an overall prevalence of 13%
among stroke/TIA survivors, with 23% prevalence in the first year
post-stroke and 11% after the first year. Given that about 85% of
the 795,000 patients who experience a stroke each year in the US
[15] survive at least 30 days [16], and up to an additional 500,000
suffer from a TIA [17], these results suggest that 297,850 stroke
and TIA survivors in the United States alone will develop PTSD
symptoms due to the event annually. Within 90 days of the index
stroke, 6% of survivors experience a recurrent stroke [18], and
recurrence rates increase substantially over longer term follow up
[19]. We do not yet know if stroke or TIA-induced PTSD is
associated with increased risk for a recurrent cerebrovascular
attack, but given the doubling of ACS recurrence risk due to ACS-
induced PTSD [3] and recent research showing that PTSD is
strongly associated with medication nonadherence [13], such
research is sorely needed.
Important caveats to this review include the fact that only
studies with relatively small sample sizes have addressed stroke-
induced PTSD, and one of the studies represented half of all of the
participants included in this review. Also, none of the included
studies used population-based sampling, and all but one study [10]
relied on cross-sectional designs (and we used only the earliest
point estimate, 1 month after stroke). Further, the PTSD screening
questionnaires used in many of the studies have not been validated
against clinical diagnosis of PTSD in survivors of stroke/TIA,
though they perform very well in other patient populations. Thus,
although this meta-analysis was able to quantify more precisely the
prevalence of stroke-induced PTSD symptoms, a clear need for









Stroke, mo Study Location N Male, % Mean Age, y
Bruggiman et al., 2006 31 IES N 1–12 Switzerland 49 67 51
Field, 2008 37 PDS N 3 United Kingdom 70 53 71
Kronish, 2012 12 PCL N 1–60 United States 535 41 63
Letamendia, 2012 4 PCL N 1 France 27 63 64
Merriman, 2007 31 PDS N 1–12 United Kingdom 102 56 74
Noble, 2008 37 PDS N 3 United Kingdom 97 43 52
Sagen, 2009 3 SCID Y 4 Norway 104 59 65
Sembi, 1998 10 CAPS Y 1–18 United Kingdom 61 NR 66
Wang, 2011 30 PDS N 1 United Kingdom 90 48 75
Abbreviations: CAPS, Clinician Administered PTSD Scale 20; IES, Impact of Events Scale 21; NR, not reported; PCL, PTSD Checklist 22; PDS, Posttraumatic Stress Diagnostic
Scale 23; PTSD, posttraumatic stress disorder; SCID, Structured Clinical Interview for DSM-IV 24; TIA, transient ischemic attack; NR, not reported.
doi:10.1371/journal.pone.0066435.t001
Figure 1. Search strategy flowchart.
doi:10.1371/journal.pone.0066435.g001
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additional research remains. It is also important to note that we
were very strict in our inclusion of only studies that measured
PTSD specifically due to the stroke event, so these estimates may
represent an underestimate of the total burden of PTSD symptoms
in these participants in so much as PTSD due to other types of
events may have been present.
The estimated prevalence of stroke-induced PTSD was lower
when PTSD was assessed by clinical interview. This may be due to
the fact that the prevalence of psychiatric disorders is often higher
when measured using diagnostic instruments as compared to
clinical psychiatric interviews Nevertheless, research on the
association between ACS-induced PTSD and ACS recurrence
and mortality risk suggests that even elevated symptoms of PTSD,
not clinical diagnosis, is associated with increased risk. Hence, the
estimate of the prevalence of PTSD symptoms based on diagnostic
instruments may still be clinically relevant [3].
Study Limitations
Prevalence estimates were limited to patients who could
participate in PTSD assessments and hence should be extrapolated
to patients with severe cognitive impairment or aphasia with
caution. Similarly, these results should be interpreted with
awareness that the mean age of the participants was slightly low
relative to the entire population of stroke survivors and PTSD is
associated with younger age in ACS-induced PTSD [3], and
therefore our rate estimate may not generalize to older stroke
survivors. We were unable to determine whether the prevalence of
PTSD differed if due to TIA or stroke, as the only study to include
TIA survivors [13] did not record the proportion of participants
Figure 2. Stroke-induced PTSD prevalence estimates. Note: The area of each square is proportional to the study’s weight in the meta-analysis,
and each line represents the confidence interval around the estimate. Diamonds represent aggregate estimates, by PTSD assessment timing and
overall, and their lateral points indicate confidence intervals for the estimates.
doi:10.1371/journal.pone.0066435.g002
Figure 3. Funnel plot to assess publication bias across prevalence studies.
doi:10.1371/journal.pone.0066435.g003
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who experienced either condition. Moreover, none of the studies
reported on the severity of the stroke event in terms of the types of
critical care that may have been necessitated such as intensive care
unit (ICU) admission.
Only one of the studies included in this review evaluated for
stroke lesion localization [6], suggesting the need to further
examine whether stroke location (i.e. hemisphere, etc) or the
nature of the associated deficits (i.e. paresis/paralysis, aphasia,
anosagnosia) further differentiate PTSD risk. Such knowledge
would allow clinicians to identify those at higher risk for PTSD to
implement early intervention. Similarly, we opted to retain one
study that focused on PTSD due to subarachnoid hemorrhage,
which clinicians and epidemiologists view as a distinct condition
from stroke/TIA, because of the similarities in patient experience
and because the aggregate estimate was not sensitive to its
exclusion. Future research should determine whether PTSD due
to subarachnoid hemorrhage is rightly grouped with PTSD due to
stroke/TIA.
It is also important to note the difference in prevalence estimates
reported in studies that assessed PTSD by screening questionnaire
versus clinical interview. Although screening questionnaires are
often used to identify patients who should be further assessed for
PTSD diagnosis–and therefore may overestimate prevalence–
reliance on screening questionnaires for estimates of stroke-
induced PTSD prevalence may further inflate those estimates
due to overlap in symptoms of stroke and PTSD. Very little is
known about the validity of PTSD questionnaire items in stroke
survivors, but the evidence that exists suggests that PTSD
questionnaires are valid in this population. In one study,
confirmatory factor analysis of responses to the PTSD Checklist-
specific for stroke conformed to the established factor structure for
PTSD due to other types of events [13]. In another small study,
PTSD severity was not related to either lesion site or neurologic
and memory deficits that could be expected to inflate PTSD
symptoms were the scale not valid [6]. Further research on the
influence of neurologic and cognitive deficits on PTSD symptom
expression is sorely needed. Finally, future research should also
consider concomitance with other comorbid stroke factors
including depression, however, it is important to note that the
effect of ACS-induced PTSD on ACS recurrence and mortality is
independent of depression [3].
Conclusions
Across published studies estimating the prevalence of stroke-
induced PTSD, two general conclusions can be drawn: (1) stroke-
induced PTSD is relatively common, with approximately one in
four experiencing PTSD in the first year after stroke and one in
nine experiencing chronic PTSD over a year later, and (2) based
on a single study, stroke-induced PTSD symptoms appear to
influence important secondary prevention behaviors such as
medication adherence [13], independent of depression. Though
no data now exist to address the issue, if the risk of stroke or other
cardiovascular event recurrence associated with stroke-induced
PTSD is comparable to that found for PTSD after ACS, stroke-
induced PTSD may be a significant, novel risk factor for recurrent
stroke, especially given its high prevalence after stroke. Screening
for PTSD in a large, population-based prospective cohort study
would yield definitive prevalence and secondary risk estimates, and
should be a priority for researchers. In the meantime, clinicians
should be mindful that PTSD can be a devastating mental health
condition and should consider screening for PTSD in stroke
survivors.
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